Details
Stereochemistry | ACHIRAL |
Molecular Formula | C9H7N5O3.H2O |
Molecular Weight | 251.1989 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
O.OC(=O)C(=O)NC1=CC=CC(=C1)C2=NN=NN2
InChI
InChIKey=LEZMUVNSMYOTNL-UHFFFAOYSA-N
InChI=1S/C9H7N5O3.H2O/c15-8(9(16)17)10-6-3-1-2-5(4-6)7-11-13-14-12-7;/h1-4H,(H,10,15)(H,16,17)(H,11,12,13,14);1H2
Molecular Formula | C9H7N5O3 |
Molecular Weight | 233.1836 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Molecular Formula | H2O |
Molecular Weight | 18.0153 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
DescriptionSources: http://www.dcchemicals.com/products_Show.asp?id=4171http://meds.qlifepro.com/detail/620006023/tazanolastCurator's Comment: description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/9150859
Sources: http://www.dcchemicals.com/products_Show.asp?id=4171http://meds.qlifepro.com/detail/620006023/tazanolast
Curator's Comment: description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/9150859
Tazanolast, an anti-allergic and anti-asthmatic agent with selective mast-cell stabilising effects, was developed jointly by Wakamoto and Torii Pharmaceuticals.
Originator
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: GO:0002553 Sources: http://www.ncbi.nlm.nih.gov/pubmed/9150859 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Palliative | Unknown Approved UseUnknown |
|||
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/2382790
0.01 and 0.033% aerosol inhalation.
Route of Administration:
Respiratory
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/9150859
WP-871 (Acitazanolast) may inhibit histamine release mainly by preventing the increase in intracellular Ca2+ concentration
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 19:39:58 GMT 2023
by
admin
on
Fri Dec 15 19:39:58 GMT 2023
|
Record UNII |
U6SU9ZSU4K
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
11954321
Created by
admin on Fri Dec 15 19:39:58 GMT 2023 , Edited by admin on Fri Dec 15 19:39:58 GMT 2023
|
PRIMARY | |||
|
DTXSID80152132
Created by
admin on Fri Dec 15 19:39:58 GMT 2023 , Edited by admin on Fri Dec 15 19:39:58 GMT 2023
|
PRIMARY | |||
|
100000127458
Created by
admin on Fri Dec 15 19:39:58 GMT 2023 , Edited by admin on Fri Dec 15 19:39:58 GMT 2023
|
PRIMARY | |||
|
U6SU9ZSU4K
Created by
admin on Fri Dec 15 19:39:58 GMT 2023 , Edited by admin on Fri Dec 15 19:39:58 GMT 2023
|
PRIMARY | |||
|
1184521-48-9
Created by
admin on Fri Dec 15 19:39:58 GMT 2023 , Edited by admin on Fri Dec 15 19:39:58 GMT 2023
|
PRIMARY | |||
|
SUB33524
Created by
admin on Fri Dec 15 19:39:58 GMT 2023 , Edited by admin on Fri Dec 15 19:39:58 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ANHYDROUS->SOLVATE | |||
|
PARENT -> SALT/SOLVATE |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |